About
Cell Therapy for Cancer
Areas of Focus
Categories
Stem Cell & Cellular TherapyBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
136
By Phase
PHASE1: 2PHASE1/PHASE2: 1
By Status
RECRUITING: 2SUSPENDED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06478693Lead Sponsor
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
PHASE1Recruiting
48 participants
Started: Jul 1, 2024 · Completed: May 31, 2026
NCT05969041Lead Sponsor
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
PHASE1Recruiting
48 participants
Started: Aug 2, 2023 · Completed: Aug 31, 2028
NCT05138458Lead Sponsor
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL
PHASE1/PHASE2Suspended
40 participants
Started: Dec 15, 2021 · Completed: Oct 31, 2025
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...